Loading...
Indian Pharmaceutical Exporter · #5 for Thalidomide · $98.7K export value · DGFT Verified
Kanchan Sagar Pharmaceuticals is the #5 Indian exporter of Thalidomide with $98.7K in export value and 5 verified shipments. Kanchan Sagar Pharmaceuticals holds a 5.1% market share in Thalidomide exports across 1 countries.
| SENEGAL | $79.2K | 5 | 4.8% |
| POLAND | $49.2K | 26 | 3.0% |
| SINGAPORE | $40.8K | 38 | 2.5% |
| EL SALVADOR | $30.7K | 4 | 1.9% |
| TURKEY | $29.2K | 40 | 1.8% |
| IRAQ | $27.0K | 63 | 1.6% |
India exports Thalidomide to 92 countries. The top destination is ALGERIA (31.3%), followed by SRI LANKA and SERBIA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SOFTCARE INTERNATIONAL(PVT)LTD | SRI LANKA | $251.3K | 10 |
| PHCEDEHO | ALGERIA | $225.1K | 9 |
| VIETNAM MEDICAL PRODUCTS IMPORT- | VIETNAM | $159.7K | 4 |
| PHCEDEHOP | ALGERIA | $132.4K | 6 |
| PHCEDEHOP PHARMACIE CENTRALE DES HOPITAUX DAREL BEIDA ALGIERS ALGIERS | ALGERIA | $111.0K | 7 |
| RHEI LIFE D.O.O BEOGRAD | SERBIA | $92.9K | 3 |
| DELTA IMPORT EXPORT MEDICAL COMPANY | VIETNAM | $62.5K | 4 |
| SOPHARMA TRADING HEAD OFFICE | SERBIA | $62.4K | 4 |
| PHARMACIE NATIONALE D'APPROVISIONNE | SENEGAL | $58.5K | 4 |
| PHARMACIE CENTRALE DES HOPITAUX | ALGERIA | $37.5K | 2 |
India's Thalidomide is purchased by 256 buyers worldwide. The top buyer is SOFTCARE INTERNATIONAL(PVT)LTD (SRI LANKA), followed by PHCEDEHO and VIETNAM MEDICAL PRODUCTS IMPORT-.
India exported $1.6M worth of Thalidomide through 822 shipments from 153 suppliers to 92 countries, serving 256 buyers globally. Kanchan Sagar Pharmaceuticals contributes $98.7K to this total, accounting for 5.1% of India's Thalidomide exports.
Kanchan Sagar Pharmaceuticals's average Thalidomide shipment value is $19.7K per consignment, based on 5 shipments totaling $98.7K.
Kanchan Sagar Pharmaceuticals ranks #5 among 153 Indian Thalidomide exporters with a 5.1% market share. The top 3 exporters are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($468.6K), UNITED BIOTECH PRIVATE LIMITED ($307.7K), JODAS EXPOIM PRIVATE LIMITED ($257.8K). Kanchan Sagar Pharmaceuticals processed 5 shipments to 1 destination countries.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | JODAS EXPOIM PRIVATE LIMITED | $257.8K | 12 | 1 | $21.5K |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $142.5K | 6 | 2 | $23.8K |
| 5 | KANCHAN SAGAR PHARMACEUTICALS ★ | $98.7K | 5 | 1 | $19.7K |
| 6 | HETERO LABS LIMITED | $86.6K | 8 | 4 | $10.8K |
| 7 | ACCURE LABS PRIVATE LIMITED | $74.5K | 4 | 1 | $18.6K |
Kanchan Sagar Pharmaceuticals ranks #5 among 153 Indian Thalidomide exporters. Average shipment value of $19.7K compared to the market average of $10.3K. The closest competitors by value are JODAS EXPOIM PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 215 | 26.2% |
| SAHAR AIR | 188 | 22.9% |
| Bombay Air | 83 | 10.1% |
| DELHI AIR CARGO ACC (INDEL4) | 65 | 7.9% |
| DELHI AIR | 63 | 7.7% |
| Bombay Air Cargo | 33 | 4.0% |
| AHEMDABAD AIR | 28 | 3.4% |
| AHEMDABAD AIR ACC (INAMD4) | 14 | 1.7% |
Latest developments and market context
Detailed market intelligence for Thalidomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 256+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kanchan Sagar Pharmaceuticals's Thalidomide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kanchan Sagar Pharmaceuticals
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Kanchan Sagar Pharmaceuticals.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Thalidomide. For current shipment-level data, contact TransData Nexus.